The poster says Ozempic, Wegovy and Mounjaro users can lose 15 to 20% of body weight, and that skin may need extra time to remodel when fat comes off quickly.
Recap by typeshit. Post by Facebook on Facebook.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
14:36
A short look at the less discussed side effects of the experimental weight loss shot retatrutide, which is still in trials and not approved.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
The hospital says tirzepatide may help with weight when medically appropriate but calls it no shortcut, urging people to understand the risks first.
More reports are surfacing of off-target effects from obesity drugs, alongside a push at HHS to move drug development faster.
Loading…